You just read:

Oncotype DX® Genomic Prostate Score® Established as First Genomic Test with Prospective Validation for Predicting Adverse Pathology in Newly Diagnosed Patients

News provided by

Genomic Health, Inc.

Feb 05, 2019, 08:00 ET